We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Bora Lim

Bora Lim MD

Assistant Professor, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Recent Contributions to PracticeUpdate:

  1. Novel Therapeutic Targets in the Management of Breast Cancer
  2. Residual Cancer Burden in TNBC Patients Receiving Neoadjuvant Chemotherapy
  3. Neoadjuvant Alpelisib Plus Nab-Paclitaxel for Triple-Negative Breast Cancer
  4. Panitumumab Plus Chemotherapy for Patients With Inflammatory Breast Cancer
  5. Atezolizumab, Cobimetinib, and Eribulin in Patients With Metastatic Inflammatory Breast Cancer
  6. TAK-228 Plus Hormonal Therapy for Metastatic, ER-Positive/HER2-Negative Breast Cancer

Most Read This Week

Recently Updated